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Particulate air pollution has been associated
with increases in daily deaths and hospital
admissions in studies all over the world
(1–15). These associations are now well doc-
umented but little is known, as yet, of the
characteristics of persons that put them at
increased risk of adverse events related to
particulate air pollution. This has been iden-
tiﬁed as a key data gap (16).
Schwartz and Dockery (17) reported that
persons older than 65 years of age had a
somewhat increased risk of death, and this
has been conﬁrmed in other studies (18). A
more detailed examination of particulate
matter-related risk by deciles of age (19)
showed the risk beginning to increase at
approximately 40 years of age and reaching
its maximum for those 75 years of age and
older.
In addition to age, several studies suggest
that persons with respiratory illness are at
increased risk for cardiovascular effects asso-
ciated with air pollution. An examination of
death certiﬁcates on high- and low-air pollu-
tion days reported a substantial difference in
the proportion of deaths from cardiovascular
causes that had respiratory disease as a con-
tributing cause of death (19). A recent fol-
low-up study of a cohort of persons with
chronic obstructive pulmonary disease
(COPD) in Barcelona, Spain, found an asso-
ciation between particulate air pollution and
all-cause mortality in the cohort (20). The
magnitude of the risk per microgram per
cubic meter of exposure was substantially
greater than that for the general population.
Controlled exposure of animals with chronic
bronchitis and control animals to concen-
trated air particles also demonstrated a
potentiating effect of chronic lung disease in
the response to airborne particles (21). This
has led to the hypothesis that the cardiovas-
cular effects of air pollution are predomi-
nantly in persons with chronic lung disease.
There has been even less done to examine
potential modiﬁers of the effects of airborne
particles on hospital admissions.
The existing literature on comorbidity
shows that comorbidity per se seems to
increase the risk of adverse outcomes (22–30).
Little is known about the role of these comor-
bidities as effect modiﬁers for the effects of air
pollution.
This study uses data from the Medicare
system to examine potential short-term and
long-term medical conditions that may
increase a person’s risk of hospital admis-
sions associated with particulate air pollu-
tion. In addition, we examine potential
effect modiﬁcation by age, race, and sex.
Materials and Methods
Health data. The Health Care Financing
Administration (Baltimore, MD) maintains
records of every hospital admission for
Medicare participants in the United States.
Persons in this database have a unique iden-
tiﬁer. Using this identiﬁer, we traced every
hospital admission for heart and lung disease
for each person in Cook County, Illinois,
between 1985 and 1994. We chose Cook
County because it is the most populous
county in the United States with daily moni-
toring for particulate matter with aerodynam-
ic diameter < 10 µm (PM10). The data were
then analyzed to look at effect modiﬁcation
by concurrent and preexisting conditions as
well as by age, race, and sex.
To establish a baseline risk, we comput-
ed daily counts of hospital admissions for
cardiovascular disease (CVD) [International
Classification of Disease, 9th edition, World
Health Organization, Geneva (ICD-9) code
390–429], pneumonia (ICD-9 code
480–487), and COPD (ICD-9 code
490–496, excluding 493). The association
between these daily counts and PM10 was
examined for the years 1988–1994, when
daily PM10 monitoring data were available
in Chicago.
Once our baseline risks were established,
we examined three classes of potential effect
modiﬁers. First, we looked at whether previ-
ous admissions for selected conditions pre-
disposed persons to having a greater risk
from air pollution. For each of the three
admission categories (CVD, pneumonia,
and COPD), we considered 10 causes
(defined by a previous admission) as effect
modifiers: COPD (ICD-9 code 490–496
except 493), asthma (ICD-9 code 493),
acute bronchitis (ICD-9 code 466), acute
respiratory illness (ICD-9 code 460–466),
pneumonia (ICD-9 code 480–487), CVD
(ICD-9 code 390–429), myocardial infarc-
tion (ICD-9 code 410), congestive heart fail-
ure (ICD-9 code 428), conduction disorders
(ICD-9 code 426), and dysrhythmias (ICD-
9 code 427). 
To test the hypothesis that persons with
these conditions had higher risks of subse-
quent PM10-related admissions, we comput-
ed separate daily counts of admissions for
our three target causes, stratiﬁed by whether
or not the person admitted had been previ-
ously admitted for the hypothesized predis-
posing condition. Separate analyses were
then performed within each strata to see if
the effects of PM10 differed by strata.
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Articles
Recent studies have shown that particulate air pollution is a risk factor for hospitalization for
heart and lung disease; however, little is known about what subpopulations are most sensitive to
this pollutant. We analyzed Medicare hospital admissions for heart disease, chronic obstructive
pulmonary disorders (COPD) and pneumonia in Chicago, Cook County, Illinois, between 1985
and 1994. We examined whether previous admissions or secondary diagnoses for selected condi-
tions predisposed persons to having a greater risk from air pollution. We also considered effect
modiﬁcation by age, sex, and race. We found that the air-pollution-associated increase in hospital
admissions for cardiovascular diseases was almost doubled in subjects with concurrent respiratory
infections. The risk was also increased by a previous admission for conduction disorders. For
COPD and pneumonia admissions, diagnosis of conduction disorders or dysrhythmias increased
the risk of particulate matter < 10 µm in aerodynamic diameter (PM10)-associated admissions.
Persons with asthma had twice the risk of a PM10-associated pneumonia admission and persons
with heart failure had twice the risk of PM10-induced COPD admissions. The PM10 effect did
not vary by sex, age, and race. These results suggest that patients with acute respiratory infections
or defects in the electrical control of the heart are a risk group for particulate matter effects. Key
words: effect modiﬁcation, hospital admissions, particulate air pollution. Environ Health Perspect
108:841–845 (2000). [Online 28 July 2000]
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conditions included secondary diagnoses
associated with the index admission. These
could represent the presence of a chronic
condition (e.g., COPD) that has not result-
ed in a previous hospital admission. They
could also represent acute conditions that
may have increased the subjects’ sensitivity
to air pollution. For example, if respiratory
infections modiﬁed the effect of particulate
matter on the cardiovascular health of per-
sons with underlying heart disease, then the
risk of a hospital admission for heart disease
might be different in persons with infec-
tions. If this were true, then the risk ratio of
a 10-µg/m3 increase of PM10 on cardiovas-
cular admissions of persons with a concur-
rent respiratory infection would be different
from the ratio in persons without respiratory
infection. To test these hypotheses, we com-
puted separate daily counts of admissions for
events with and without the concurrent con-
ditions hypothesized to increase sensitivity to
air pollution. These were taken as the same
10 conditions in the ﬁrst analysis with cer-
tain exclusions for pairing that would be
illogical. That is, the concurrent diagnosis of
a speciﬁc cardiac condition was not treated
as an effect modiﬁer for admissions for any
cardiovascular condition. Likewise, pneumo-
nia and COPD were not possible concurrent
conditions for each other.
The third set of predisposing conditions
considered was being older than 75 years of
age, nonwhite, and female. These were
examined for all three outcomes.
We obtained weather data for O’Hare
Airport from the EarthInfo CD-ROM
(EarthInfo CD NCDC Surface Airways,
EarthInfo Inc., Boulder, CO), and we
obtained air pollution data from the U.S.
Environmental Protection Agency Aerometric
Information Retrieval System network (31). 
Methods
We analyzed the data with a generalized
additive robust Poisson regression model
(32). This approach has become the norm in
such studies (14,33,34). In the generalized
additive model the outcome is assumed to
depend on a sum of nonparametric smooth
functions for each variable that models the
potential nonlinear dependence of daily
admission on weather and season. The
model is of the form:
log[E(Yt)] = α 0+ S1 (X1 )+… + Sp (Xp)
where E(Yt) is the expected value of the daily
count of admissions Yt and Si are the smooth
functions of the covariates Xi. We examined
temperature, previous day’s temperature, rel-
ative humidity, barometric pressure, and day
of week covariates. The locally weighted
running-line smoother, loess (35), was cho-
sen to estimate the smooth function. 
To control for weather variables and day
of the week, we chose the smoothing parame-
ter that minimized the Akaike’s information
criterion (36). 
To model seasonality we chose the
smoothing parameter that minimized the sum
of the autocorrelation of the residuals while
removing seasonal patterns. Two autoregres-
sive terms (37) were added in the model to
eliminate the remaining serial correlation
from the residuals. We used the mean of
PM10 on the day of the admission and the
day before the admission as our exposure vari-
able. This gives results that are similar to
those obtained fitting a full distributed lag
model (38). PM10 was treated linearly.
Our baseline models used the daily
counts of CVD, pneumonia, and COPD
admissions as outcomes. We then subdivid-
ed those counts by the presence or absence
of the potential effect modifier and reesti-
mated our regressions on those subgroups.
We considered effect modiﬁcation to be
indicated when the estimates of PM10 in the
group with the condition was outside of the
95% confidence interval (CI) of the effect
estimate in persons without the condition.
Results
Table 1 shows the mean daily admissions for
COPD, cardiovascular, and pneumonia
both overall and in the presence of the
potential effect modiﬁers.  For some effect
modifiers such as conduction disorders or
myocardial infarctions, the counts in con-
junction with our respiratory outcomes are
low, which limits power. In general, the
numbers are lower for examining effect
modification by previous admissions than
for effect modiﬁcation by concurrent diag-
nosis. This is as expected because many clini-
cally relevant comorbidities may never have
resulted in a hospital admission. 
Table 2 shows the 25th, 50th, and 75th
percentile values for the environmental vari-
ables. The mean value for PM10 is 33 µg/m3.
The daily values for PM10 were computed as
the average of 10 monitors, two of which
measured PM10 almost every day and the
others less frequently (38).
Table 3 shows the mean daily counts of
CVD, COPD, and pneumonia by sex, age
groups, and race. The distribution by sex is
almost even, although the counts of admis-
sions for males are generally lower (approxi-
mately 10%) than for females, particularly
for cardiovascular diseases. The counts of
CVD, COPD, and pneumonia admissions
were similar for people 65–75 or 75 years of
age and older.
Tables 4–6 show the results for the effect
PM10 overall and stratifying by concurrent
diagnosis and previous admissions. These are
expressed as the percentage increase for 10
µg/m3 PM10.
Table 4 shows the results for CVD. A
10-µg/m3 increase in PM10 was associated
with a 1.31% (5% CI, 0.97%; 95% CI,
1.66%) increase in hospital admissions for
heart disease in all elderly persons. A concur-
rent (not previous) diagnosis of COPD
modiﬁed the risk of PM10-associated admis-
sions for heart disease. However, signiﬁcant
associations were still seen between PM10
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Table 1. Mean daily counts of admissions, Chicago 1986–1994, for COPD, CVD, and pneumonia overall and
by concurrent diagnosis and by previous admissions. 
By concurrent diagnosis By previous admissions
COPD CVD Pneumonia COPD CVD Pneumonia
Overall 7.8 102.1 26.5 7.8 102.1 26.5
Respiratory disease
Acute bronchitis 0.1 0.9 0.3 0.8 1.6 0.9
Acute respiratory infections 0.3 1.3 0.3 0.9 1.8 1.0
Pneumonia 0.4 4.0 NA 1.6 7.3 6.4
Asthma 0.1 1.8 0.9 0.9 1.5 0.7
COPD NA 13.4 6.9 2.7 2.0 1.4
Cardiovascular disease
CVD 4.7 NA 14.7 2.1 54.7 7.2
Conduction disorders 0.2 NA 0.6 0.0 1.0 0.2
Cardiac dysrhythmias 1.4 NA 4.6 0.4 9.9 1.5
Congestive heart failure 1.8 NA 7.3 0.9 24.2 3.1
Myocardial infarction 0.1 NA 0.4 0.3 11.4 1.0
NA, not applicable. 
Table 3. Mean daily counts of admissions by sex,
race, and age groups, Chicago, 1986–1994.
Group COPD CVD Pneumonia
Overall 7.8 102.1 26.5
Female 4.2 59.4 14.7
Nonwhite 1.6 21.0 5.2
Age > 75 years 3.7 55.1 17.4
Table 2. 25th, 50th, and 75th percentile values for
the environmental variables in Chicago, 1988–1994.
Temperature Relative Barometric PM10
(°F) humidity pressure (µg/m3)
35 62 29.2 23
51 70 29.3 33
67 79 29.4 46and heart disease admissions in persons
without COPD listed as either a comorbidi-
ty or a cause of previous admission (Table
4). A signiﬁcant association was also seen in
persons without any respiratory disease as a
concurrent diagnosis, although the risk is
much lower than in persons with respiratory
disease. However, the risk associated with
PM10 was roughly doubled in subjects with
concurrent respiratory infections and the risk
estimates in those subjects were outside the
95% CI of the risk in patients without con-
current respiratory infections. 
A previous admission for conduction dis-
orders (e.g., heart block) increased the risk of
a PM10-related subsequent admission for any
heart condition, and a weaker indication of
effect modiﬁcation was seen for persons with
previous admission for dysrhythmias. In
contrast heart failure and previous myocar-
dial infarctions were highly insigniﬁcant as
effect modiﬁers.
Table 5 shows the results for COPD.
Overall, there is a 1.89% (95% CI, 0.8–3.0)
increase in COPD admissions for a 10-
µg/m3 increase in PM10. 
The results of the stratiﬁed analysis sug-
gest that preexisting heart disease modifies
the risk of COPD admissions on high parti-
cle days. Previous admissions for any cardio-
vascular disease increased the risk of a PM10-
associated COPD admission approximately
2.5-fold. A previous heart failure admission
caused an even more striking increase in the
PM10 effect. Previous admissions for dys-
rhythmias and conduction defects were rare
(Table 1) with no power to examine effect
modifications. Listings as concurrent diag-
noses were more common and here they
joined heart failure in increasing the risk of
PM10-associated COPD admissions. For
COPD there was also some indication that
concurrent pneumonia or an acute respirato-
ry infection admission in the last year
increased risk. The low numbers made these
estimates less precise, however.
The percentage increase in pneumonia
admission (Table 6) for 10 µg/m3 PM10 is
higher than for COPD or CVD with an
increase of 2.34% (95% CI, 1.66–3.0).
As with COPD, persons with heart dis-
ease appeared at higher risk of pneumonia
hospital admissions associated with particu-
late air pollution. Here diagnoses suggestive
of impaired autonomic control of the heart,
such as conduction disorders or dysrhyth-
mias, were associated with increased risk for
PM10 effects on pneumonia admissions.
Unlike COPD, no difference was seen for
congestive heart failure. Persons with asthma
had twice the risk of a PM10-induced pneu-
monia admission as persons without asthma.
Table 7 shows the results by sex, age, and
race. None of the effect size estimates for any
of the stratiﬁcation variables were outside of
the 95% CI for the opposite strata. There
was a tendency for the effect of PM10 on
CVD admissions to be higher for females,
whereas the effect on pneumonia admissions
was higher for males. In general, we found
somewhat larger effects on whites compared
to nonwhites, and for persons older than 75
years of age compared to younger persons.
Discussion
In this analysis we examined whether the
effect of PM10 on the risk of hospital admis-
sion for heart and lung disease was different
depending on the presence of comorbidities.
We found that PM10 was associated with
hospital admissions for all three causes
(CVD, COPD, and pneumonia) and we
found not a general increase in PM10 related
risk with comorbidities, but a specific pat-
tern that is suggestive of potential mecha-
nisms and consistent with other recent
epidemiologic and toxicologic ﬁndings.
One major ﬁnding of this study is that
preexisting cardiovascular disease, particularly
impaired autonomic control (conduction
defects and dysrhythmias) and heart failure,
substantially increased the risk of respiratory
admissions associated with airborne particles.
In fact, recent human studies have shown
that exposure to particulate air pollution is a
risk factor for reduced heart rate variability
(39–41). Reduced heart rate variability is an
adverse response and a risk factor for arrhyth-
mia. A new study of deﬁbrillator discharges in
patients with implanted cardioverter deﬁbrilla-
tors found that discharges were associated with
air pollution (42). Exposure to combustion
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Table 4. Percentage increase in hospital admis-
sions for CVD in all persons and by concurrent
diagnosis and previous admissions. 
PM10 2.5% CI 97.5% CI




With 1.65 1.10 2.20
Without 0.98 0.64 1.33
Acute bronchitis
With 2.50 –0.47 5.55
Without 1.07 0.76 1.37
Acute respiratory infections
With 2.71 0.18 5.30
Without 1.06 0.76 1.37
Pneumonia
With 1.95 0.55 3.36
Without 1.03 0.72 1.35
COPD
With 1.59 0.85 2.34




With 1.18 0.45 1.91
Without 1.08 0.76 1.41
COPD
With 1.48 –0.40 3.40
Without 1.09 0.78 1.40
Asthma
With 1.71 –0.43 3.89
Without 1.08 0.77 1.39
Cardiovascular disease
Conduction disorders
With 2.89 0.22 5.63
Without 1.07 0.76 1.38
Cardiac dyshrethmias
With 1.61 0.75 2.48
Without 1.04 0.72 1.36
Increases are for a 10-µg/m3 increase in PM10.
Table 6. Percentage increase in hospital admis-
sions for pneumonia in all persons and by concur-
rent diagnosis and previous admissions. 
PM10 2.5% CI 97.5% CI




With 4.18 1.01 7.46
Without 2.07 1.46 2.69
Cardiovascular disease
Conduction disorders
With 7.92 4.28 11.69
Without 1.99 1.37 2.61
Cardiac dysrhythmias
With – – –




With 3.47 1.21 5.79
Without 2.08 1.45 2.71
Increases are for a 10-µg/m3 increase in PM10.
Table 5. Percentage increase in hospital admis-
sions for COPD in all persons and by concurrent
diagnosis and previous admissions. 
PM10 2.5% CI 97.5% CI




With 4.00 –0.45 8.65
Without 1.51 0.47 2.57
Cardiovascular disease
Conduction disorders
With 2.34 –4.42 9.59
Without 1.60 0.58 2.64
Cardiac dysrhythmias
With 3.09 0.64 5.60
Without 1.43 0.33 2.55
Congestive heart failure
With 2.90 0.77 5.08




With 3.20 –1.38 8.01
Without 1.70 0.66 2.76
Cardiovascular disease
CVD
With 2.90 0.99 4.85
Without 1.18 –0.01 2.39
Congestive heart failure
With 4.37 1.43 7.40
Without 1.14 0.05 2.24
Within 1 year 6.04 2.10 10.14
Increases are for a 10-µg/m3 increase in PM10.particles has also been associated with
arrhythmia in an animal model (43) and
changes in ST segments have been noted as
well (44). This is the ﬁrst study to suggest
persons with defects in the electrical control
of the heart are also at higher risk of respirato-
ry illness after exposure to airborne particles. 
These data also suggest that persons
admitted to hospitals for pneumonia during
an air pollution episode may be at high risk
for clinically signiﬁcant conduction disorders
during that hospital admission.
Patients with congestive heart failure
were at greater risk of hospital admissions
for COPD in association with airborne
particles. Heart failure and COPD is not an
uncommon combination. The ﬁnding that
these patients are at higher risk for admis-
sions associated with particulate air pollu-
tion is new but is also consistent with
several other recent reports. The sponta-
neous hypertensive rat develops a model of
heart failure, and recent studies have report-
ed greater sensitivity to particulate air pollu-
tion in these rats. These include both
electrocardiogram abnormalities (44) and
pulmonary toxicity (45,46). Similarly, in an
epidemiologic study, Hoek et al. (47),
found a higher relative risk of death with an
increase in PM10 for congestive heart failure
deaths than other deaths. The potential role
of COPD in those heart failure deaths was
not examined.
Another consistent pattern in our data is
of acute respiratory infections increasing
susceptibility to airborne particles. Acute
bronchitis, or more generally acute upper
respiratory illnesses, as well as pneumonia,
increased susceptibility to particle-associated
admissions for CVD and COPD. The
notion that air pollution exacerbates acute
respiratory infections is well supported by
studies which report associations between
airborne particles and hospital admissions
for respiratory infections (48,49). Zelikoff et
al. (50) exposed rats infected with strepto-
coccus to concentrated air particles and
reported a significant increase in bacterial
burdens and in the extent of pneumonia
compared to animals exposed to filtrated 
air. This suggests an impaired immune
response. Similarly, exposure to combustion
particles enhances influenza infections in
mice (51).
An impaired defense to respiratory infec-
tion is a major reason that persons with
COPD require hospital admission. If air-
borne particles result in further impairment
the effect modification we observe makes
good sense. The effect modiﬁcation for heart
disease admissions is more relevant. This
modification is consistent with the earlier
report of Schwartz (19), who found greater
reports of respiratory complications on death
certiﬁcates with an underlying cause of heart
disease if the death occurred on a day with
high levels of airborne particles. 
Although airborne particle exposure has
been associated with increased exacerbation
of asthma (2,12,48,52–59), this paper is the
ﬁrst to suggest that asthmatics are more sus-
ceptible to PM10-induced pneumonia exac-
erbation or to cardiovascular effects. The
effects on pneumonia admissions are plausi-
ble, given the impaired ability to fight off
infections in asthmatics with mucus plugs
and the evidence the airborne particles
impair the lungs’ ability to ﬁght off bacterial
and viral infections, as noted earlier. The
increased cardiovascular sensitivity, albeit
weaker, is interesting. If airborne particles
affect the cardiovascular system via the role
of the lung in autonomic control, it is possi-
ble that asthmatics would be more sensitive
to those effects. Animal models of asthma
showed that combustion particles enhance
the asthmatic response to aeroallergen chal-
lenges (59). This suggests an enhancement
of pulmonary response in asthmatics. On the
other hand, the diagnosis of asthma is prob-
lematic in the elderly, and crossover with
COPD is possible. The possibility that this
explains our results is reduced by our failure
to find previous hospital admission for
COPD was an effect modiﬁer for the effect
of particles on cardiovascular admissions.
We must acknowledge several potential
limitations of this study. First, we considered
only previous admissions that occurred
within Cook County. Hence persons with
previous admissions elsewhere would be mis-
classiﬁed to our reference group. The effect
of this would be to reduce the difference in
PM10 effect between the two groups.
Nevertheless, we identiﬁed some interesting
interactions. We cannot exclude the possibil-
ity that there are areas we missed for this rea-
son. We also examined interactions in a log
relative risk model, which is inherently mul-
tiplicative. Although we believe this is justi-
fied because doubling the population
exposed would be expected to double the
pollution associated admissions, it results in
a more conservative deﬁnition of interaction
than would an additive risk model. Finally,
our exposure is clearly measured with error.
Most of this error is Berkson error (60) and
hence will introduce no bias, and Zeger et al.
(60) showed that the remaining error would
have to have pathologic correlations with
other variables to result in an upward bias.
Another important result from this
study, of course, is an estimate of the magni-
tude of the effect of airborne particles on
public health. The PM10 concentrations in
Chicago during this period were associated
with approximately 1,600 additional admis-
sions per year for heart disease, 740 addi-
tional admissions per year for pneumonia,
and 170 additional admissions per year for
COPD. These are not trivial increases in
serious morbidity. 
The results of our study should be repli-
cated in additional cities, although they do
begin to fill in some missing information
about the effects of airborne particles on
health.
More generally airborne particles have
been associated with a broad range of sys-
temic changes including heart rate variabili-
ty (39–41), increased peripheral neutrophils
(61–63), increased plasma viscosity (64), an
increase in blood pressure (65), and the out-
comes mentioned previously. The role of
these systemic changes as potential sources
of the speciﬁc effect modiﬁcations we have
seen should be an area of fruitful research in
the future.
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